Evrofarma SA (EVRr)

Athens

Currency in EUR

2.740

-0.010(-0.36%)

Closed·24/10

Fair Value

Unlock Value

Day's Range

2.670

2.790

52 wk Range

1.330

2.920

EVRr Financial Summary

A brief financial summary of Evrofarma SA as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio15.63

Price/Book1.74

Debt / Equity95.41%

Return on Equity13.23%

Dividend Yield1.82%

EBITDA5.31M

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Income Statement

Total Revenues

aa.aa

33.48

33.91

36.7

45.38

48.76

Gross Profit

aa.aa

6.06

4.99

3.84

5.8

7.06

Operating Income

aa.aa

2.19

1.48

0.23

2.26

3.66

Net Income

aa.aa

0.16

1.06

-0.36

1.42

2.2

Balance Sheet

Total Assets

aa.aa

41.2

46.38

46.52

48.81

47.36

Total Current Liabilities

aa.aa

22.25

10.71

10.2

12.67

13.04

Total Equity

aa.aa

11.87

12.96

12.61

14.03

16.23

Cash Flow

Levered Free Cash Flow

aa.aa

0.8

0.06

-2.44

0.42

0.68

Cash from Operations

aa.aa

1.78

1.46

-0.81

2.64

3.14

Cash from Investing

aa.aa

-0.86

-0.81

-3.27

-1.33

-2.02

Cash from Financing

aa.aa

-1.37

2.35

1.21

-0.12

-1.9

Net Change in Cash

aa.aa

-0.45

-2.86

1.19

-0.78

* In Millions of EUR (except for per share items)

Dividends

Payout Ratio

Payout ratio (TTM)

Earnings retained

EPS 0.16%

Dividend Yield

1.82%

Industry Median 3.55%

Annualised payout

0.05

Paid annually

5-Years Growth

Growth Streak

Unlock

Earnings

Latest Release

Sep 27, 2025

EPS / Forecast

0.13 / --

Revenue / Forecast

24.32M / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were Evrofarma SA's earnings for the latest quarter?

The Evrofarma SA EPS (TTM) is 0.16. Evrofarma SA reported sales of 24.32, net income of 1.81, and EPS of 0.13 for the latest quarter.

What was Evrofarma SA's net income for the latest quarter?

Evrofarma SA's net income for the latest quarter was 1.81.

How did Evrofarma SA's performance compare year-over-year in the latest quarter?

The company's revenue moved from 21.65 in the previous quarter to 24.32 in the latest quarter, and net income moved from 1.40 to 1.81 compared to the previous quarter.

What is Evrofarma SA's net profit margin on a TTM basis?

Evrofarma SA's trailing twelve months (TTM) net profit margin is 4.52%.

How does Evrofarma SA's debt to equity ratio compare to industry standards?

Evrofarma SA's total debt-to-equity ratio is 95.41%.

What is Evrofarma SA's return on investment on a TTM basis?

Evrofarma SA's trailing twelve months (TTM) return on investment (ROI) is 13.23%.

Did Evrofarma SA gain or lose cash last quarter?

In the latest quarter, Evrofarma SA's net change in cash was 4.20 million.

What were Evrofarma SA's total assets and liabilities in the latest quarter?

As of the latest quarter, Evrofarma SA reported total assets of 57.47 million and total liabilities of 10.55 million.

How has Evrofarma SA's total revenue grown this year?

Evrofarma SA's total revenue was 21.65 in the previous quarter and 24.32 in the latest quarter.

What was Evrofarma SA's revenue per share for the latest quarter?

Evrofarma SA's revenue per share for the latest quarter was 65.50.

NSE 30

5,692.66

+42.59

+0.75%

NSE All Share

155,645.03

+1,155.13

+0.75%

US 30

47,199.50

+464.9

+0.99%

US 500

6,791.60

+53.2

+0.79%

FTSE 100

9,645.62

+67.05

+0.70%

DAX

24,239.89

+32.10

+0.13%

South Africa Top 40

103,114.20

-227.67

-0.22%

Market Movers

Name	Last	Chg. %	Vol.
Fidelitybk	19.850	+0.25%	820.91M
Access Holdings	25.00	+0.20%	23.75M
Guaranty Trust Holding	92.50	-0.32%	19.18M
Zenith Bank	67.20	-0.52%	15.06M
Aradel Holdings	790.00	+6.76%	4.70M
MTN Nigeria	515.00	+0.98%	2.56M
Dangote Cement	665.00	+2.42%	1.21M

Name	Last	Chg. %	Vol.
Asosavings	0.66	+10.00%	604.00K
Ikeja	20.500	+7.89%	1.34M
Regal Insurance	1.30	+7.44%	3.68M
Caverton Offshore Support	6.500	+7.08%	3.47M
Aradel Holdings	790.00	+6.76%	4.70M
Nem	30.000	+6.76%	1.58M
Nigerian Breweries	74.50	+6.43%	5.83M

Name	Last	Chg. %	Vol.
Union Dicon Salt	8.00	-9.09%	3.27M
Neimeth	5.60	-6.67%	2.08M
Cornerst	6.23	-5.61%	752.59K
International Energy Insurance	2.77	-4.48%	335.26K
Livingtrust Mortgage Bank	4.01	-4.07%	449.42K
Npfmcrfbk	3.140	-3.68%	3.65M
Lafarge Africa	145.00	-3.62%	3.39M

Trending Stocks

Name	Last	Chg. %	Vol.
Aradel Holdings	790.00	+6.76%	4.70M
MTN Nigeria	515.00	+0.98%	2.56M
Lafarge Africa	145.00	-3.62%	3.39M
Dangote Cement	665.00	+2.42%	1.21M
Asosavings	0.66	+10.00%	604.00K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaa	5,917.20	+46.07%	8,643.25
A Aaa Aaaaaa	1,915.00	+31.99%	2,527.61
A A Aaaaaaaa A	665.00	+14.95%	764.42
Aaaaaa Aa A	640.00	+13.85%	728.64

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Evrofarma SA (EVRr)

EVRr Financial Summary

Key Ratios

Statements Highlights

Dividends

Earnings

FAQ

What were Evrofarma SA's earnings for the latest quarter?

What was Evrofarma SA's net income for the latest quarter?

How did Evrofarma SA's performance compare year-over-year in the latest quarter?

What is Evrofarma SA's net profit margin on a TTM basis?

How does Evrofarma SA's debt to equity ratio compare to industry standards?

What is Evrofarma SA's return on investment on a TTM basis?

Did Evrofarma SA gain or lose cash last quarter?

What were Evrofarma SA's total assets and liabilities in the latest quarter?

How has Evrofarma SA's total revenue grown this year?

What was Evrofarma SA's revenue per share for the latest quarter?

Trending Stocks